203 related articles for article (PubMed ID: 36428607)
21. Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy.
van der Heijden M; Essers PBM; Verhagen CVM; Willems SM; Sanders J; de Roest RH; Vossen DM; Leemans CR; Verheij M; Brakenhoff RH; van den Brekel MWM; Vens C
Radiother Oncol; 2020 Jun; 147():186-194. PubMed ID: 32413532
[TBL] [Abstract][Full Text] [Related]
22. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
[TBL] [Abstract][Full Text] [Related]
23. Associations of MACC1, AGR2, and KAI1 expression with the metastasis and prognosis in head and neck squamous cell carcinoma.
Sun B; Cheng Z; Sun J
Int J Clin Exp Pathol; 2018; 11(2):822-830. PubMed ID: 31938171
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
[TBL] [Abstract][Full Text] [Related]
25.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
26. Role of miRNA in head and neck squamous cell carcinoma.
Masood Y; Kqueen CY; Rajadurai P
Expert Rev Anticancer Ther; 2015 Feb; 15(2):183-97. PubMed ID: 25367254
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel hub genes associated with lymph node metastasis of head and neck squamous cell carcinoma by completive bioinformatics analysis.
Lu H; Li L; Sun D; Duan Y; Yue K; Wu Y; Wang X
Ann Transl Med; 2021 Nov; 9(22):1678. PubMed ID: 34988187
[TBL] [Abstract][Full Text] [Related]
28. The Prognostic Value of Toll-Like Receptors in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Hasnat S; Hujanen R; Nwaru BI; Salo T; Salem A
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33008143
[TBL] [Abstract][Full Text] [Related]
29. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA LOC541471: A novel prognostic biomarker for head and neck squamous cell carcinoma.
Wu H; Yu DH; Wu MH; Huang T
Oncol Lett; 2019 Feb; 17(2):2457-2464. PubMed ID: 30675311
[TBL] [Abstract][Full Text] [Related]
31. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract][Full Text] [Related]
32. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma.
Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W
Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090
[TBL] [Abstract][Full Text] [Related]
33. Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India.
Nair S; Mohan S; Nilakantan A; Gupta A; Malik A; Gupta A
World J Nucl Med; 2015; 14(1):19-24. PubMed ID: 25709540
[TBL] [Abstract][Full Text] [Related]
34. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
[TBL] [Abstract][Full Text] [Related]
35. [Clinicopathologic features and risk factors of bilateral cervical lymph node metastasis in head and neck squamous cell carcinoma].
Di B; Li X; Song Q; Liu S; Tao Z; Xiao S
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 May; 49(5):404-9. PubMed ID: 25017226
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
37. Research Progress in Head and Neck Squamous Cell Carcinoma: Best Abstracts of ICHNO 2015.
Economopoulou P; Bourhis J; Psyrri A
Am Soc Clin Oncol Educ Book; 2015; ():e323-8. PubMed ID: 25993192
[TBL] [Abstract][Full Text] [Related]
38. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
39. Study of Podoplanin Expression in Head and Neck Squamous Cell Carcinoma.
Mary Jibi A; Basavaraj V
Iran J Pathol; 2022; 17(3):275-284. PubMed ID: 36247509
[TBL] [Abstract][Full Text] [Related]
40. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma.
Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N
Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
